Litigation Details for Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd. (D. Del. 2021)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd. (D. Del. 2021)
Docket | ⤷ Sign Up | Date Filed | 2021-10-27 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:1 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Patents | 10,543,179 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd.
Details for Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd. (D. Del. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2022-02-24 | 15 | Notice of Service | Preliminary Invalidity Contentions Regarding U.S. Patent No. 10,543,179 filed by HEC Pharm Co., Ltd., HEC Pharm … 27 October 2021 1:21-cv-01530 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2021-10-27 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,543,179. (myr) (Entered: 10… 27 October 2021 1:21-cv-01530 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |